Shelter Pharma Ltd
₹0.00▲ +0.00 (+0.00%)
SHELTERPHARMALTD·NSE·Healthcare
Market Cap
51.50 Cr
PE Ratio
5.70
Volume
—
Day High - Low
—
52W High-Low
46.88 - 23.00
₹0.00▲ +0.00 (+0.00%)
Market Cap51.50 Cr
PE Ratio5.70
Volume—
Day High - Low—
52W High-Low46.88 - 23.00
Shelter Pharma Ltd (SHELTERPHARMALTD): company summary
Shelter Pharma Ltd (SHELTERPHARMALTD) is a micro-cap Healthcare company valued at ₹52 crore operating in Pharmaceuticals on the NSE and BSE.
Shelter Pharma Ltd (SHELTERPHARMALTD) is a micro-cap Healthcare company valued at ₹52 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 26.5% a year over three years; profit grew 20.2% a year, behind revenue — margins are under pressure. Return on equity is 15.1%.
- Valuation multiples
- The stock trades at 5.7 times earnings, a discount to the Healthcare median of 32.0, 0.71 times book value. It yields 1.1%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
7.4/10
Strong
Fair Value
Sign in to see
ROE
15.10%
Strong
P/E
5.70x
Cheap
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Strong
Price performance
52W₹23.00
₹46.88
DocStoX take
Supported by growth (10.0) and valuation (9.0), but weakest on risk (5.0). Scored on 4 of 5 measures.
DocStoX score
Medium confidence7.4
/10
Strong
Quality
Solid
ROE 15.1%
Valuation
Cheap
P/E 5.7×
Growth
Strong
Revenue +26.6% 5Y CAGR
Risk
Moderate
D/E 0.01
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹52 Cr
52W High / Low
₹47 / ₹23
Dividend Yield
1.14%
Promoter Holding
44.38%
EPS (TTM)
₹6.26
Book Value
₹43.16
Key highlights
- Profit compounding 196% a year
- Low leverage — D/E 0.01
- Profitable in all of the last 5 years
- Small ₹52 cr company — thinner liquidity
4 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Shelter Pharma Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Shelter Pharma Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Shelter Pharma Ltd with peers
Shelter Pharma Ltd vs Sun Pharmaceutical Industries LimitedShelter Pharma Ltd vs Divi's Laboratories LimitedShelter Pharma Ltd vs Torrent Pharmaceuticals LimitedShelter Pharma Ltd vs Apollo Hospitals Enterprise LimitedShelter Pharma Ltd vs Zydus Lifesciences LimitedShelter Pharma Ltd vs Laurus Labs Limited
Related tools & concepts
Value Shelter Pharma Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing